Cover Image

The human IL-15 superagonist N803 does not reverse latency in ART-suppressed, SHIV-infected macaques

Saved in:

Bibliographic Details
Main Authors:	G. Webb (Author), J. Berrocal (Author), K. Busman-Sahay (Author), S. Abdulhaqq (Author), J. Smedley (Author), J. Safrit (Author), J. Estes (Author), P. Skinner (Author), J. Sacha (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sustained SHIV reactivation by N-803 in ART-treated CD8-depleted macaques
by: J.B. McBrien, et al.
Published: (2019)

The human IL-15 superagonist complex ALT-803 drives SIV-specific CD8+ T cells into B cell follicles
by: G. Webb, et al.
Published: (2017)

Treatment of SHIV-infected, ART-suppressed rhesus macaques with bispecific HIVxCD3 DART® molecules
by: Daniel M. Gorman, et al.
Published: (2019)

OP 6.6 - 00134 Viral Suppression in SHIV-infected Rhesus Macaques following AAVmediated Delivery of Closer-to-germline Monoclonal Antibodies
by: J. Martinez-Navio, et al.
Published: (2022)

The latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques is potentiated by CD8a cell depletion
by: M. Mavigner, et al.
Published: (2019)

Novel SHIVs encoding transmitted/founder envs for latency and cure research
by: K. Bar, et al.
Published: (2017)

Novel SHIVs encoding transmitted/founder Envs for latency and cure research
by: A. Bauer, et al.
Published: (2019)

Different regimens of romidepsin administration for reversion of SIV latency in a rhesus macaque model of complete virus control
by: A. Kleinman, et al.
Published: (2019)

Differential viral rebound between lymph node and colon after treatment interruption in SHIV-infected rhesus macaques
by: D.C. Hsu, et al.
Published: (2017)

OP 6.3 - 00150 Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV for ART-free remission from SHIV viremia
by: G. Webb, et al.
Published: (2022)

CD8 depletion plus signaling of the non-canonical NF-kB pathway reverses latency in SIV-infected, ART-suppressed rhesus macaques
by: M. Mavigner, et al.
Published: (2019)

Delay in viral rebound with TLR7 agonist, N6-LS and PGT121 in SHIV-infected macaques
by: D. Hsu, et al.
Published: (2019)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

OA2-1 Frequent and 'burst-like' reactivation from latency in SIVmac239M infected macaques
by: M. Pinkevych, et al.
Published: (2016)

Therapeutic efficacy of optimized eCD4-Ig proteins in SHIV-infected rhesus macaques
by: M.R. Gardner, et al.
Published: (2017)

PP 8.7 - 00098 The sequestration and expansion of effector lymphocytes in lymphoid tissue using combination FTY720 and N-803 immunotherapy at ART initiation fails to limit SIV persistence
by: J. Harper, et al.
Published: (2022)

Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART
by: A.A. Okoye, et al.
Published: (2019)

PP 8.13 - 00191 Investigating the Impact of CD4 mimetic BNM-III-170 on SHIV-infected Rhesus Macaques
by: E. Viox, et al.
Published: (2022)

Antiretroviral drug activity in macaque PrEP breakthrough infections has only a transient effect on cell-associated SHIV DNA reservoirs
by: J.G. García-Lerma, et al.
Published: (2015)

CD4+ T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques
by: Naoki Saito, et al.
Published: (2014)

Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure.
by: Agnès-Laurence Chenine, et al.
Published: (2008)

SIV/SHIV-Zika co-infection does not alter disease pathogenesis in adult non-pregnant rhesus macaque model.
by: Mehdi R M Bidokhti, et al.
Published: (2018)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

PP 1.22 - 00120 Suppression of CD4+ T-cell-intrinsic immunity by HIV-1 latency-reversing HDACi
by: J. Kazmierski, et al.
Published: (2022)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

OP 2.8 - 00193 Enhancing PKC Modulator HIV Latency Reversing Agents
by: M. Marsden, et al.
Published: (2022)

α4β7-blockade delays viral rebound in SHIV infected macaques treated with a combination of HIV bNAbs
by: E. Martinelli
Published: (2019)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019)

Approaches to discover latency-reversing agents
Published: (2015)

Latency-reversing agents and cellular activation affect antigen processing in primary CD4 T cells
by: J. Boucau, et al.
Published: (2015)

Scientific American Supplement, No. 803, May 23, 1891
by: Various

Donor T cell chimerism correlates with viral reservoir clearance following allogeneic stem cell transplantation in fully cART-suppressed Mauritian cynomolgus macaques
by: Helen L. Wu, et al.
Published: (2019)

Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes in lymph nodes and reduces SHIV RNA
by: G. Pavlakis, et al.
Published: (2017)

Tissue-specific effects of latency-reversing agents on HIV transcriptional blocks in gut and blood
by: S. Telwatte, et al.
Published: (2019)

In situ multiplex RNA fluorescence imaging of SHIV1157ipd3N4 and anti-HIV CAR T cells to study CAR T cell trafficking to sites of viral reservoir in macaque lymphoid tissues
by: K. Eichholz, et al.
Published: (2017)

Brain macrophages in SIV-infected ART-suppressed macaques represent a functional latent reservoir
by: J. Clements, et al.
Published: (2017)

Fully MHC-matched allogeneic hematopoietic stem cell transplantation in SIV-infected, cART-suppressed Mauritian cynomolgus macaques indicates GVHD as a reservoir clearance mechanism
by: H.L. Wu, et al.
Published: (2017)

No evidence of neuroaxonal injury following latency reversal with vorinostat and HIV-1 specific vaccination in the RIVER trial
by: J. Alagaratnam, et al.
Published: (2019)

A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
by: R. Ke, et al.
Published: (2015)